Research Assistant - New Platform for Next-Generation Intraocular Biologics (NIB)

Job Offer #2026-RDG-J03 open until September 30, 2026

Research Assistant - New Platform for Next-Generation Intraocular Biologics (NIB)

35 days left to apply!

About BioMed X and XSeed Labs

BioMed X is a leading innovation engine where disruptive ideas in biomedical research and development come to life. With our global network of research institutes and venture-creating incubators, embedded within major innovation hubs, we bridge the gap between academic research and the needs of the pharmaceutical industry.

We are pioneers in applying the principles of design thinking and crowdsourcing to drug discovery and development. With our unique model, we partner with pharma, venture capital, and patient-focused foundations to identify key challenges across all therapeutic areas, recruit top talent, and co-create tailored solutions.

In our stimulating ecosystem, talented researchers from all around the globe grow into industry-ready scientific leaders. They perform exploratory research, deliver industry-grade results, and pave the way for next-generation therapies. At BioMed X, we value curiosity, diversity, and purpose. Together, we serve as a vital catalyst for innovation in global health – for the benefit of all patients.

Our XSeed Labs site is located on the research campus of Boehringer Ingelheim in Ridgefield, Connecticut, USA. Together with our partners, we solve high-impact biomedical research challenges and by combining global crowdsourcing and local incubation of the worlds brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry.

About Team NIB

Biologic therapies have transformed retinal disease management, but the burden of frequent intraocular injections remains a significant barrier to patient adherence and comfort. Efforts to significantly increase the half-life of intraocular biologics (e.g., via PEGylation) were mostly unsuccessful since they result in reduced retinal penetration and low efficacy. Hence, there is an urgent need for a fundamentally novel biologics design principle, enabling long-term intraocular activity and at the same time deep retinal penetration.

The newly established research team aims to develop an innovative human organotypic in vitro platform technology for the development and validation of next-generation intraocular biologics. This initiative builds on Boehringers growing focus in eye health, where the company is pursuing innovative approaches to address vision-threatening diseases and exploring next-generation biologics to help preserve and improve sight. Retinal conditions are a leading cause of irreversible vision loss globally, with many patients still lacking treatment options.

Team NIB aims to develop an innovative platform technology for the design and validation of next-generation intraocular biologics capable of effectively modulating pharmacological targets deep within the retina while substantially extending the time between intraocular injections. Team NIB is a fully funded research group at its incubator on the research campus of Boehringer Ingelheim.

The Position

We are looking for highly enthusiastic research assistant to contribute to the project on development of a novel in vitro human retina model. We are looking for cell biologists and bioengineers who have hands-on experience in cell culture and organ-on-chip models.